CLBT Maintained by DA Davidson -- Price Target Stays at $15
gurufocus.com · 2026-09-15
Cellebrite DI Ltd (CLBT) Analyst Rating Update On September 15, 2026, DA Davidson maintained a "Buy" rating for Cellebrite DI (CLBT). The current price targe
TickrTrends take: DA Davidson's maintained price target of $15 for CLBT suggests analyst confidence in the current trajectory of the Technology sector company, which aligns with TickrTrends' assessment that the stock is currently undervalued. For valuation-focused investors, the stability of this price target indicates the research community sees limited near-term catalyst for significant revision, making the gap between current market price and the $15 target a key metric to monitor as earnings or sector developments emerge. Any material changes to DA Davidson's stance would signal shifting fundamentals that could affect the valuation thesis.
Read the full story at gurufocus.com →
Is CLBT undervalued? See TickrTrends' fair value analysis →